Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02308137
Recruitment Status : Recruiting
First Posted : December 4, 2014
Last Update Posted : April 17, 2019
Alberta Innovates Health Solutions
Information provided by (Responsible Party):
Dr. Marcus Werner Koch, University of Calgary

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020